Art & Science of Patient Behavior: Medication Adherence in the Digital Age

Event Information

Share this event

Date and Time

Location

Location

BioLabs@NYULangone

180 Varick Street

6th Floor

New York, NY 10014

View Map

Event description

Description

A HITLAB Seminar Series Event
Sponsored by Information Mediary and hosted by BioLabs@NYULangone

Close out September with a deep dive into patient behavior and medication adherence with Jason Lazar, MD, Distinguished Professor of Medicine at SUNY Downstate Health Sciences University, and Jenny Sheng, Director, US Tafamidis Marketing at Pfizer, at the upcoming HITLAB Seminar Series. Jason and Jenny will lead a discussion with researchers and scientists who have spent their careers understanding and guiding patient behavior.

Agenda: September 26

6:00 - 6:30 PM: Registration & Drinks
6:30 - 7:30 PM: Fireside Chat
7:30 - 8:00 PM: Networking

Meet Dr. Jason Lazar

Jason Lazar, MD, MPH is a Distinguished Teaching Professor of SUNY. He is Professor of Medicine, Neurology, Public Health, Molecular and Cell Biology, Director, Non-Invasive Cardiology and former Director of Cardiology Fellowship Training Program at SUNY Downstate Medical Center. Jason received his medical degree from the SUNY Upstate Medical Center at Syracuse and completed his postgraduate training at the University of Pittsburgh Medical Center in Pennsylvania. He received his MPH from Columbia University School of Public Health. Jason is currently Director of Non-Invasive Cardiology and Clinical Assistant Dean in the College of Medicine. His research interests include: brain-heart interactions, arterial stiffness, the epidemiology of coronary heart disease in women and in high-risk populations, and health disparities. He is a member of the editorial board of multiple journals and serves as a reviewer for numerous peer-reviewed journals. He is widely published with more than 150 peer-reviewed manuscripts and has embarked upon several international collaborations, including medical missions to various countries.

He is a Fellow of the American College of Physicians, the American College of Cardiology, the American Heart Association and the American College of Chest Physicians. He has previously served as Chair of the Cardiovascular Network and New York State representative of the Governor’s Council of the American College of Chest Physicians, and on the American Society of Echocardiography Research Committee. He has received multiple accolades for academia including the SUNY Chancellor's Award for Excellence in Scholarship and Creative Activities. He currently serves as Co-Principal Investigator of a multicenter R01 grant investigating mechanism of left ventricular dysfunction in HIV infection. Over the past decade, Jason has been awarded four different New York State Department of Health Empire Clinical Research Investigator Program (ECRIP) Training Grants, and now serves as SUNY Downstate’s ECRIP Committee Chair and liaison to the Department of Health.

Meet Jenny Sheng

Jenny is a healthcare strategist with a passion for innovation. She is currently Director, US Tafamidis Marketing at Pfizer and serves as the Innovation Strategist and Business Development Associate for the Innovation Forum NYC, whose mission is to foster the NYC innovation ecosystem by bringing together startups, investors, incubators, academia, industry, among others. Prior to Pfizer, Jenny worked in management consulting and at an angel investment firm. She has a Master in Business of Bioscience (MBS) from Keck Graduate Institute and a Bachelor of Science (BS) in Psychobiology from UCLA.




About Information Mediary:

Information Mediary Corp (IMC) is the global leader in smart medication adherence solutions, having supplied over a million units to the clinical trials and research markets. IMC manufactures iOS and Android NFC-enabled Med-ic Smart Blister Packages, eCAP Smart Medication Bottles and the temperature-aware Med-ic Smart Syringe Pack. The company is active in the AI-enabled digital health field, offering its HIPAA compliant, secure CertiScan clinical research adherence cloud. IMC’s latest Lilipond AI project is aimed at detecting opiate abuse early to avoid dependence and addiction.

About the HITLAB Seminar Series:

HITLAB's Seminar Series bridges the gap between academic and professional healthcare. Our series serves as an outlet to facilitate connections and provide networking and growth opportunities for digital health professionals.

Since 2007, our Seminar Series has brought together leading experts – including scientists, physicians, IT architects, public health practitioners, and investors – who share a single vision: to design and scale innovative technologies that improve health outcomes around the world.

Questions? Contact seminars@hitlab.org

Date and Time

Location

BioLabs@NYULangone

180 Varick Street

6th Floor

New York, NY 10014

View Map

Save This Event

Event Saved